DNAVSGRAL• 3 Months (Normalized)
DNA vs GRAL (Ginkgo Bioworks Holdings Inc. vs GRAIL Inc.)
Showing Closing Date Range from Jul 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $10.46
+%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
GRAL Performance $136.57
+97.61%
GRAIL Inc.
Normalized Baseline0.00%
Alpha Spread Margin GRAL LEADS
-97.61 pts
GRAL outperforming by 97.61 percentage points
DNAGRAL
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA GRAL
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | DNA Price | DNA Gain (%) | GRAL Price | GRAL Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $136.57 | +97.61% | - | |
| Sep 28, 2026 | $10.46 | +0.58% | $132.63 | +91.91% | -91.33% |
| Sep 25, 2026 | $10.66 | +2.50% | $126.89 | +83.61% | -81.11% |
| Sep 24, 2026 | $10.25 | -1.44% | $125.21 | +81.17% | -82.61% |
| Sep 23, 2026 | $8.58 | -17.50% | $108.52 | +57.03% | -74.53% |
| Sep 22, 2026 | $9.37 | -9.90% | $108.52 | +57.03% | -66.93% |
| Sep 21, 2026 | $7.98 | -23.27% | $107.97 | +56.23% | -79.50% |
| Sep 18, 2026 | $7.88 | -24.23% | $80.77 | +16.87% | -41.10% |
| Sep 17, 2026 | $7.84 | -24.62% | $79.95 | +15.69% | -40.31% |
| Sep 16, 2026 | $7.06 | -32.12% | $75.11 | +8.68% | -40.80% |
| Sep 15, 2026 | $6.99 | -32.79% | $75.89 | +9.81% | -42.60% |
| Sep 14, 2026 | $7.01 | -32.60% | $75.53 | +9.29% | -41.89% |
| Sep 11, 2026 | $6.75 | -35.10% | $76.23 | +10.30% | -45.40% |
| Sep 10, 2026 | $6.78 | -34.81% | $77.56 | +12.23% | -47.04% |
| Sep 09, 2026 | $6.79 | -34.71% | $77.48 | +12.11% | -46.82% |
Page 1 of 5